Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
[forminator_form id="25163"]

Moderna said on Wednesday, November 4, that WHO advisers have recommended its experimental Bundibugyo ebolavirus vaccine, mRNA-1469, for a Phase 2/3 efficacy study in the Democratic Republic of the Congo. The company said early clinical results were encouraging. The World…

The death toll from the Democratic Republic of Congo's Ebola outbreak has reached at least 930, with 2,344 confirmed cases as of Saturday, Congo's Ministry of Health announced Monday, as escalating U.S. and Congolese travel restrictions draw warnings from aid…

Healthcare workers at the epicenter of Congo's Ebola outbreak walked off their jobs last week, staging protests outside treatment centers in the country's northeast over wages they say have gone unpaid since the crisis began nearly two months ago.

Scientists trying to develop vaccines and treatments for the fast-growing Bundibugyo Ebola outbreak in Central Africa are running into a basic problem: too little is known about the strain, and the response is being shaped by delayed detection, limited diagnostics…